O'Shaughnessy Asset Management’s AtriCure ATRC Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,718	Closed	-$310K	–	1256
2022 Q1	$310K	Buy	4,718 +838	+22%	+$54.3K	0.01%	881
2021 Q4	$270K	Buy	3,880 +77	+2%	+$5.6K	﹤0.01%	923
2021 Q3	$265K	Buy	3,803 +655	+21%	+$50.4K	0.01%	904
2021 Q2	$250K	Buy	3,148 +2,879	+1,070%	+$209K	0.01%	923
2021 Q1	$18K	Hold	269	–	–	﹤0.01%	1654
2020 Q4	$15K	Hold	269	–	–	﹤0.01%	1461
2020 Q3	$11K	Hold	269	–	–	﹤0.01%	1330
2020 Q2	$12K	Buy	+269	New	+$11.7K	﹤0.01%	1224
2020 Q1	–	Sell	-269	Closed	-$9K	–	1323
2019 Q4	$9K	Buy	+269	New	+$7.66K	﹤0.01%	1321

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

O'Shaughnessy Asset Management's ATRC Position: Q2 2022 in Review

O'Shaughnessy Asset Management sold out of AtriCure (ATRC) in Q2 2022, closing a stake of 4,718 shares — an estimated $310K sold.

O'Shaughnessy Asset Management first reported a position in ATRC in Q4 2019 and held it in 9 quarters. The position peaked at $310K in Q1 2022. 213 funds tracked by Wall St. Rank hold ATRC as of Q2 2022.

O'Shaughnessy Asset Management reported no remaining AtriCure position as of Q2 2022 after selling out during the quarter.
O'Shaughnessy Asset Management sold 4,718 AtriCure shares in Q2 2022, an estimated $310K.
O'Shaughnessy Asset Management first reported a position in AtriCure in Q4 2019 and held it in 9 quarters.
O'Shaughnessy Asset Management's AtriCure position peaked at $310K in Q1 2022.
213 funds tracked by Wall St. Rank held AtriCure as of Q2 2022.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2022, filed 11 Aug 2022.